Literature DB >> 8122621

Syncope, bradycardia, and atrioventricular block associated with topical ophthalmic levobunolol.

J G Chun1, M A Brodsky, B J Allen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8122621     DOI： 10.1016/0002-8703(94)90682-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  Severe bradycardia and syncope due to topical ophthalmic timolol.

Authors:  U Canpolat; K M Gürses; K Aytemir; A Oto
Journal:  Herz       Date:  2013-01-23       Impact factor: 1.443

2.  Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers.

Authors:  Jillian G Baker; Christophe Fromont; Marjorie Bruder; Kevin S J Thompson; Barrie Kellam; Stephen J Hill; Sheila M Gardiner; Peter M Fischer
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-01

3.  Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.

Authors:  Lianjun Lin; Yuchuan Wang; Yan Chen; Meilin Liu
Journal:  Clin Interv Aging       Date:  2014-10-13       Impact factor: 4.458
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.